BRCA2 and pancreatic neoplasm: Interestingly, pancreas cancer was also more frequent in double heterozygotes of a BRCA1 pathogenic variant and BRCA2 c.9976A>T variant, suggesting a potential genetic modifier effect (Table 2, Figure 2).